Informed consent model for patients with tumor lysis syndrome

Authors

Keywords:

bioethics ; informed consent; tumor lysis syndrome

Abstract

Introduction: Tumor lysis syndrome is one of the major paradoxes of oncology, where the most effective treatment can also be the most lethal. Its wide range of occurrence leads to a series of ethical dilemmas, among which the lack of specific informed consent for communicating with patients stands out.

Objective: To propose an informed consent model for patients with tumor lysis syndrome.

Development: Informed consent should explicitly state what the patient needs to know, the risks involved in the treatment and prevention, as well as their preferences and decisions. All this should be achieved through an assessment of the patient's comprehension capacity and strategies to avoid information overload during the continuous deliberative process, with the participation of accompanying persons, institutional and multidisciplinary validation of the recording and monitoring of outcomes.

Conclusions: Despite being a random, overrated, and underestimated event, tumor lysis syndrome should be addressed through informed consent that explains its occurrence and consequences.

Downloads

Download data is not yet available.

References

1. Rodríguez Gómez R. Consentimiento informado en investigación clínica: revisión de la literatura 2012-2022 [Internet]. Rev Latinoam Bioet. 2025 [acceso: 09/04/2026]; 25(1): 37-56. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657-47022025000100037

2. Correa Rodríguez JG. Los criterios de Cairo-Bishop y la imperativa necesidad de un marco ético para el síndrome de lisis tumoral [Internet]. EsTuSalud. 2026 [acceso: 10/04/2026]; 8(1): e486. Disponible en: https://revestusalud.sld.cu/index.php/estusalud/article/view/486.

3. Correa Rodríguez JG. ¿Supervivencia a qué precio? Redefiniendo la calidad de vida en la encrucijada entre el síndrome de lisis tumoral y la terapia curativa [Internet]. Univ Méd Pinareña. 2025 [acceso: 08/04/2026]; 21(1): e1479. Disponible en: https://revgaleno.sld.cu/index.php/ump/article/view/1479

4. Correa Rodríguez JG, Castell Martínez LM, Mesa Quesada M de J, Licea Rodríguez MA. Dilemas éticos en el síndrome de lisis tumoral en tumores sólidos: revisión y marco integrador [Internet]. Gac méd estud. 2026 [acceso: 13/04/2026]; 7(1):e705. Disponible en: https://revgacetaestudiantil.sld.cu/index.php/gme/article/view/705

5. Correa Rodríguez JG, Castell Martínez LM, Mesa Quesada MdJ. Hacia un protocolo ético para el síndrome de lisis tumoral: primeros pasos para su confección [Internet]. MedEst. 2026 [acceso: 10/04/2026]; 6(1): e519. Disponible en: https://revmedest.sld.cu/index.php/medest/article/view/519

6. Alqurashi RM, Tamim HH, Alsubhi ZD, Alzahrani AA, Tashkandi E. Tumor Lysis Syndrome in Patients With Solid Tumors: A Systematic Review of Reported Cases [Internet]. Cureus. 2022 [acceso: 09/04/2026]; 14(10): e30652. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9685209/

7. Serrano Franco FJ. El consentimiento informado como un continuo narrativo [Internet]. Rev Bioética y Derecho. 2022 [acceso: 10/04/2026]; (54): 83-102. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1886-58872022000100006&lng=es

8. Hurtado Enríquez MG, Mendoza Panta DA, Padrón Fernández L. Consentimiento informado en la atención de pacientes en cuidados paliativos. Una revisión sistemática [Internet]. Conectividad. 2024 [acceso: 10/04/2026]; 5(4): 131-45. Disponible en: https://revista.ister.edu.ec/ojs/index.php/ISTER/article/view/179

9. Fando Couso E, Reyes de la Paz A, Arteche Hidalgo LL, Hernández León Y. Comunicación de la verdad en oncología desde la visión de la bioética médica [Internet]. Rev Cubana Med Milit. 2022 [acceso: 10/04/2026]; 51(3): e2049. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/2049

10. Suárez Cuevas A, Gómez Marrero O, Ramos Fernández JM. Fundamentos bioéticos y aspectos prácticos del consentimiento informado en el contexto de la cirugía oncológica [Internet]. Rev. Cub. Cir. 2024 [acceso: 10/04/2026]; 63(1): 1528. Disponible en: https://www.revcirugia.sld.cu/index.php/cir/article/view/1528

11. Gómez Álvarez JE, Chávez Hernández NH. Análisis del consentimiento informado en pacientes con cáncer: una propuesta de algoritmo decisional [Internet]. Medicina y ética. 2021; 32(2): 553-582. DOI: https://doi.org/10.36105/mye.2021v32n2.05

12. Álvarez Gómez RM, Vargas Huichochea I, Herrera Montalvo LA, Álvarez del Río MA. El consentimiento informado en cáncer hereditario [Internet]. Gac. mex. oncol. 2023 [acceso: 10/04/2026]; 22(1): 34-40. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2565-005X2023000100034&lng=es

13. Chan YLT, El-Sharkawi D, Shah P, et al. British Society for Haematology updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children with haematological malignancies: A focus on patient safety [Internet]. Br JHaematol. 2025 [acceso: 10/04/2026]; 207(4): 1248-58. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70092

14. Rodríguez JGC, Martínez LMC, Fiqueredo N del RB. Towards a risk classification for tumor lysis syndrome in solid neoplasms [Internet]. SAP Health and Policy. 2026 [acceso: 10/04/2026]; 5(1): 326. Disponible en: https://shp.southam.pub/index.php/shp/article/view/326

15. Cairo MS, Coiffier B, Reiter A, Younes A; TLS Expert Panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus [Internet]. Br J Haematol. 2010 [acceso 10/04/2026]; 149(4): 578-86. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08143.x

16. Perissinotti AJ, Bishop MR, Bubalo J, et al. Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel. Cancer Treat Rev. 2023; 120(1): 102603. DOI: 10.1016/j.ctrv.2023.102603

Published

2026-11-16

How to Cite

1.
Correa Rodríguez JG, Castell Martínez LM, Licea Rodríguez MA. Informed consent model for patients with tumor lysis syndrome. Rev. cuba. med. mil [Internet]. 2026 Nov. 16 [cited 2026 Nov. 17];55(4):e026077621. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/77621